3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
10
Thoracic
1
NET
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Lymphoma
666
Lymphoma, Non-Hodgkin
593
Leukemia, Lymphocytic, Chronic, B-Cell
535
Precursor Cell Lymphoblastic Leukemia-Lymphoma
485
Lymphoma, Follicular
418
Lymphoma, Large B-Cell, Diffuse
379
Leukemia
358
Hodgkin Disease
354
Lymphoma, Mantle-Cell
306
Leukemia, Myeloid, Acute
250
Multiple Myeloma
237
Myelodysplastic Syndromes
214
Lymphoma, B-Cell, Marginal Zone
196
Recurrence
195
Burkitt Lymphoma
189
Waldenstrom Macroglobulinemia
155
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
130
Lymphoma, B-Cell
127
Neoplasms
118
Lymphoma, T-Cell, Cutaneous
116
Lymphoma, Large-Cell, Anaplastic
113
Hematologic Neoplasms
103
Lymphoma, Large-Cell, Immunoblastic
100
Mycosis Fungoides
95
Myeloproliferative Disorders
94
Sezary Syndrome
86
Lymphoma, T-Cell, Peripheral
83
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
74
Primary Myelofibrosis
70
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Diseases
×
Lymphoid
×
Clear all
NCT00210249
2022-02-04
PHRC2003
Institut Bergonié
Completed
364 enrolled
4 charts